Lieping Chen
Impact in
- Immunology top 0.01%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immune cells in cancer
- Immune Response and Inflammation
- Oncology top 0.01%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Immunology 267
- Immunotherapy and Immune Responses 189
- Immune Cell Function and Interaction 147
- T-cell and B-cell Immunology 99
- Immune Response and Inflammation 28
- Immune cells in cancer 12
- Oncology 172
- Cancer Immunotherapy and Biomarkers 132
- CAR-T cell therapy research 70
- Co-authors
- Dallas B. Flies (39 shared papers)Koji Tamada (56 shared papers)Gefeng Zhu (41 shared papers)Weiping Zou (10 shared papers)Haidong Dong (20 shared papers)Miguel F. Sanmamed (18 shared papers)Drew M. Pardoll (19 shared papers)Xue Han (14 shared papers)
- Journals
- The Journal of Immunology (46 papers)Blood (28 papers)Journal of Clinical Investigation (16 papers)Cancer Research (13 papers)Clinical Cancer Research (12 papers)
- Partner nations
- United StatesChinaGermany
In The Last Decade
Lieping Chen
361 papers receiving 55.5k citations
Lieping Chen's Hit Papers
Peers
Comparison fields: 5 of 164
- Immunology 32.3k
- Oncology 30.7k
- Cancer Research 2.7k
- Pulmonary and Respiratory Medicine 4.9k
- Genetics 1.3k
Countries citing papers authored by Lieping Chen
This map shows the geographic impact of Lieping Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lieping Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lieping Chen more than expected).
Fields of papers citing papers by Lieping Chen
This network shows the impact of papers produced by Lieping Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lieping Chen. The network helps show where Lieping Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Lieping Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 369 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion Hit paper breakdown → | 2002 | 4013 |
| 2 | Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates Hit paper breakdown → | 2010 | 2352 |
| 3 | Molecular mechanisms of T cell co-stimulation and co-inhibition Hit paper breakdown → | 2013 | 2323 |
| 4 | B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion Hit paper breakdown → | 1999 | 2077 |
| 5 | PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations Hit paper breakdown → | 2016 | 1891 |
| 6 | Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti–PD-1 Therapy Hit paper breakdown → | 2014 | 1885 |
| 7 | Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape Hit paper breakdown → | 2012 | 1685 |
| 8 | Inhibitory B7-family molecules in the tumour microenvironment Hit paper breakdown → | 2008 | 1321 |
| 9 | Anti–PD-1/PD-L1 therapy of human cancer: past, present, and future Hit paper breakdown → | 2015 | 1169 |
| 10 | A Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization Hit paper breakdown → | 2018 | 1133 |
| 11 | Co-inhibitory molecules of the B7–CD28 family in the control of T-cell immunity Hit paper breakdown → | 2004 | 1035 |
| 12 | Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4 Hit paper breakdown → | 1992 | 913 |
| 13 | B7-H3: A costimulatory molecule for T cell activation and IFN-γ production Hit paper breakdown → | 2001 | 836 |
| 14 | Blockade of B7-H1 and PD-1 by Monoclonal Antibodies Potentiates Cancer Therapeutic Immunity Hit paper breakdown → | 2005 | 798 |
| 15 | Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors Hit paper breakdown → | 1997 | 728 |
| 16 | Programmed death ligand-1 expression in non-small cell lung cancer Hit paper breakdown → | 2013 | 654 |
| 17 | Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target Hit paper breakdown → | 2004 | 638 |
| 18 | Evidence for a Role of the PD-1:PD-L1 Pathway in Immune Resistance of HPV-Associated Head and Neck Squamous Cell Carcinoma Hit paper breakdown → | 2013 | 608 |
| 19 | B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma Hit paper breakdown → | 2006 | 582 |
| 20 | B7-H4, a Molecule of the B7 Family, Negatively Regulates T Cell Immunity Hit paper breakdown → | 2003 | 569 |
About Lieping Chen
Lieping Chen is a scholar working on Immunology, Oncology, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Epidemiology, having authored 369 papers that have together received 56.2k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (189 papers), Immune Cell Function and Interaction (147 papers), Cancer Immunotherapy and Biomarkers (132 papers), T-cell and B-cell Immunology (99 papers), CAR-T cell therapy research (70 papers), Immune Response and Inflammation (28 papers), Monoclonal and Polyclonal Antibodies Research (16 papers) and Immune cells in cancer (12 papers). The work is most often cited by research in Immunology (32.3k citations), Oncology (30.7k citations), Cancer Research (2.7k citations), Pulmonary and Respiratory Medicine (4.9k citations) and Genetics (1.3k citations). Lieping Chen has collaborated with scholars based in United States, China and Germany. Frequent co-authors include Dallas B. Flies, Koji Tamada, Gefeng Zhu, Weiping Zou, Haidong Dong, Miguel F. Sanmamed, Drew M. Pardoll, Xue Han, Jedd D. Wolchok and Scott E. Strome. Their work appears in journals such as The Journal of Immunology, Blood, Journal of Clinical Investigation, Cancer Research and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.